NxStage wins nocturnal dialysis CE Mark

February 19, 2013 by MassDevice staff

NxStage Medical notches CE Mark approval in the European Union for nocturnal use of its System 1 home hemodialysis device.

NxStage Medical wins CE Mark for nocturnal dialysis

NxStage Medical (NSDQ:NXTM) said it won CE Mark approval in the European Union for its System 1 home hemodialysis device, saying it expects to begin marketing the device for that indication in the 2nd half of this year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp